In particular we highlight the possible role TLR4 in AD through (a) its up-regulation, (b) its modulation by TYROBP, DOK3, TREM2 and INPP5D, and (c) its signalling through NFKB leading to microglial NO and complement activation. This evidence concerns the gene TREM2 and Alzheimer disease.